IVAN JAVIER
NUÑEZ GIL
PROFESOR
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (24)
2024
-
Prognostic Utility of Society for Cardiovascular Angiography and Interventions Shock Stage Approach for Classifying Cardiogenic Shock Severity in Takotsubo Syndrome
Journal of the American Heart Association, Vol. 13, Núm. 6, pp. e032951
-
Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort
International Journal of Cardiology, Vol. 405
2023
-
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
Journal of Clinical Medicine, Vol. 12, Núm. 16
2022
-
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136
-
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry
Journal of the American Heart Association, Vol. 11, Núm. 13
-
Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing
PLoS ONE, Vol. 17, Núm. 2 February
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing
Journal of Clinical Medicine, Vol. 11, Núm. 20
-
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry
Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 9, pp. 2520-2528
2021
-
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633
-
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
Infection, Vol. 49, Núm. 4, pp. 677-684
-
Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry
Cardiovascular Revascularization Medicine, Vol. 29, pp. 22-28
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
Age and ageing, Vol. 50, Núm. 2, pp. 326-334
-
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19
Journal of hospital medicine, Vol. 16, Núm. 6, pp. 349-352
-
Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis
BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292
-
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases
Archivos de Bronconeumologia, Vol. 57, pp. 13-20
-
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data
Medicina Clinica, Vol. 157, Núm. 7, pp. 318-324
-
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
American Heart Journal, Vol. 237, pp. 104-115
-
Stent strut thickness and acute vessel injury during percutaneous coronary interventions: An optical coherence tomography randomized clinical trial
Coronary Artery Disease, Vol. 32, Núm. 5, pp. 382-390